ENDV (Endonovo Therapeutics) FCF Margin %: 0.00% (As of Jun. 2025)


What is Endonovo Therapeutics FCF Margin %?

Endonovo Therapeutics ENDV FCF Margin % is 0.00% as of Jun. 2025. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Endonovo Therapeutics ranks better than 99.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Endonovo Therapeutics's Free Cash Flow for the three months ended in Jun. 2025 was $-0.03 Mil. Endonovo Therapeutics's Revenue for the three months ended in Jun. 2025 was $0.00 Mil. Therefore, Endonovo Therapeutics's FCF Margin % for the quarter that ended in Jun. 2025 was 0.00%.

As of today, Endonovo Therapeutics's current FCF Yield % is 42.54%.

The historical rank and industry rank for Endonovo Therapeutics's FCF Margin % or its related term are showing as below:

ENDV' s FCF Margin % Range Over the Past 10 Years
Min: -25575   Med: -661.81   Max: 1000
Current: 770

During the past 13 years, the highest FCF Margin % of Endonovo Therapeutics was 1000.00%. The lowest was -25575.00%. And the median was -661.81%.

ENDV's FCF Margin % is ranked better than
99.69% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs ENDV: 770.00

Endonovo Therapeutics FCF Margin % Related Terms

Endonovo Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics FCF Margin % Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -446.99 -1,352.05 -502.96 87.14 1,000.00

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 0.00 0.00 0.00 0.00

ENDV vs RGBP, IOBTQ, CNBX: FCF Margin % Comparison

For the Biotechnology subindustry, Endonovo Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's FCF Margin % falls into.


Endonovo Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Endonovo Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=0.1/0.01
=1,000.00 %

Endonovo Therapeutics's FCF Margin for the quarter that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=-0.025/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Endonovo Therapeutics (ENDV) has a FCF Margin % of 0.00% as of Jun. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Endonovo Therapeutics and its competitors. According to the industry distribution chart, Endonovo Therapeutics ranks #3 out of 960 companies in the Biotechnology industry, placing it in the top 0.3%.
Is Endonovo Therapeutics' FCF Margin % too high?
Endonovo Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Endonovo Therapeutics ranks #3 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Endonovo Therapeutics' FCF Margin % compare to RGBP and IOBTQ?
According to the Biotechnology industry distribution chart, Endonovo Therapeutics ranks #3 out of 960 companies for FCF Margin %. This places Endonovo Therapeutics in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current FCF Margin % is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.